Pipeline Programs↗
Distinct drugs in development (Preclinical–Phase 3)
Indications↗
Distinct diseases across all programs
Clinical Trials↗
All sponsored trials (all statuses)
Pipeline
By Phase
1 drugs in development
By Therapeutic Area
top 1
R&D Momentum
70/100
Pipeline Velocity
37/100
Trial Completion Rate
76/100
Pipeline Concentration
50/100
Pipeline Freshness
74/100
Strategic Signals
Activity
Last 14 days
An Augmented Reality Based System for Neglect Detection, Assessment, and Rehabilitation
Cognitive and Affective Mechanisms Underlying an Olfactory Approach to Modify Cigarette Craving: A Neurobehavioral Investigation
Impact of Harm Reduction Care in HIV Clinical Settings on Stigma and Health Outcomes
Reach and Scalability of Digital Therapeutics for Childhood Behavior Problems
Testicular Tissue Cryopreservation in the Setting of Gender-Affirming Therapy
Ovarian Tissue Cryopreservation in the Setting of Gender-affirming Therapy
Retrospective and Longitudinal Prospective Natural History Study of GEMIN5-Related Neurodevelopmental Disorder
Autologous Ovarian Tissue Transplantation
Center for Adolescent Reward, Rhythms and Sleep Project 2
Open Trial of a Technology-Based Intervention for Dysregulated Eating in Adolescents With or At Risk for Overweight or Obesity
Details
Company Overview
—
Mkt Cap
—
Revenue
—
Cash
Pipeline
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)